Connection

Hugh Myrick to Substance Withdrawal Syndrome

Back to Details
This is a "connection" page, showing publications Hugh Myrick has written about Substance Withdrawal Syndrome.
Hugh Myrick
Connection Strength
1.716
Substance Withdrawal Syndrome
  1. Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics. Psychopharmacology (Berl). 2013 Jun; 227(4):627-37.
    View in: PubMed
    Score: 0.326
  2. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res. 2009 Sep; 33(9):1582-8.
    View in: PubMed
    Score: 0.252
  3. A retrospective chart review comparing tiagabine and benzodiazepines for the treatment of alcohol withdrawal. J Psychoactive Drugs. 2005 Dec; 37(4):409-14.
    View in: PubMed
    Score: 0.198
  4. Novel anticonvulsants in the treatment of alcoholism. Expert Opin Investig Drugs. 2005 Apr; 14(4):371-6.
    View in: PubMed
    Score: 0.189
  5. Gabapentin treatment of alcohol withdrawal. Am J Psychiatry. 1998 Nov; 155(11):1632.
    View in: PubMed
    Score: 0.121
  6. Treatment of alcohol withdrawal. Alcohol Health Res World. 1998; 22(1):38-43.
    View in: PubMed
    Score: 0.114
  7. Neural correlates of craving and resisting craving for tobacco in nicotine dependent smokers. Addict Biol. 2011 Oct; 16(4):654-66.
    View in: PubMed
    Score: 0.073
  8. Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence. Alcohol Clin Exp Res. 2011 Nov; 35(11):2030-8.
    View in: PubMed
    Score: 0.072
  9. Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms. J Clin Psychopharmacol. 2009 Aug; 29(4):334-42.
    View in: PubMed
    Score: 0.064
  10. A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm. Alcohol Clin Exp Res. 2007 Feb; 31(2):221-7.
    View in: PubMed
    Score: 0.054
  11. Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. Am J Addict. 2006 Jan-Feb; 15(1):105-10.
    View in: PubMed
    Score: 0.050
  12. The use of divalproex in the treatment of addictive disorders. Psychopharmacol Bull. 2003; 37 Suppl 2:89-97.
    View in: PubMed
    Score: 0.040
  13. Update on anticonvulsants for the treatment of alcohol withdrawal. Am J Addict. 2001; 10(s1):s16-s23.
    View in: PubMed
    Score: 0.035
  14. New developments in the pharmacotherapy of alcohol dependence. Am J Addict. 2001; 10(s1):s3-s15.
    View in: PubMed
    Score: 0.035
  15. Multiple previous detoxifications are associated with less responsive treatment and heavier drinking during an index outpatient detoxification. Alcohol. 2000 Nov; 22(3):159-64.
    View in: PubMed
    Score: 0.035
  16. Gabapentin combined with naltrexone for the treatment of alcohol dependence. Am J Psychiatry. 2011 Jul; 168(7):709-17.
    View in: PubMed
    Score: 0.018
  17. Risk factors for delirium tremens: a retrospective chart review. Am J Addict. 2006 May-Jun; 15(3):213-9.
    View in: PubMed
    Score: 0.013
  18. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med. 2002 May; 17(5):349-55.
    View in: PubMed
    Score: 0.010
  19. The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification. Am J Addict. 2002; 11(2):141-50.
    View in: PubMed
    Score: 0.009
  20. Gabapentin abuse in a cocaine user: implications for treatment? J Clin Psychopharmacol. 1997 Oct; 17(5):423-4.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.